IL-4 regulates specific Arg-1(+) macrophage sFlt-1-mediated inhibition of angiogenesis

Am J Pathol. 2015 Aug;185(8):2324-35. doi: 10.1016/j.ajpath.2015.04.013. Epub 2015 Jun 13.

Abstract

One of the main drivers for neovascularization in age-related macular degeneration is activation of innate immunity in the presence of macrophages. Here, we demonstrate that T helper cell type 2 cytokines and, in particular, IL-4 condition human and murine monocyte phenotype toward Arg-1(+), and their subsequent behavior limits angiogenesis by increasing soluble fms-like tyrosine kinase 1 (sFlt-1) gene expression. We document that T helper cell type 2 cytokine-conditioned murine macrophages neutralize vascular endothelial growth factor-mediated endothelial cell proliferation (human umbilical vein endothelial cell and choroidal vasculature) in a sFlt-1-dependent manner. We demonstrate that in vivo intravitreal administration of IL-4 attenuates laser-induced choroidal neovascularization (L-CNV) due to specific IL-4 conditioning of macrophages. IL-4 induces the expression of sFlt-1 by resident CD11b(+) retinal microglia and infiltrating myeloid cells but not from retinal pigment epithelium. IL-4-induced suppression of L-CNV is not prevented when sFlt-1 expression is attenuated in retinal pigment epithelium. IL-4-mediated suppression of L-CNV was abrogated in IL-4R-deficient mice and in bone marrow chimeras reconstituted with myeloid cells that had undergone lentiviral-mediated shRNA silencing of sFlt-1, demonstrating the critical role of this cell population. Together, these data establish how lL-4 directly drives macrophage sFlt-1 production expressing an Arg-1(+) phenotype and support the therapeutic potential of targeted IL-4 conditioning within the tissue to regulate disease conditions such as neovascular age-related macular degeneration.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Arginase / metabolism*
  • Cell Proliferation / drug effects
  • Choroidal Neovascularization / metabolism*
  • Disease Models, Animal
  • Humans
  • Interleukin-13 / pharmacology
  • Interleukin-4 / pharmacology*
  • Macrophages / drug effects
  • Macrophages / metabolism*
  • Mice
  • Retina / drug effects
  • Retina / metabolism
  • Retinal Pigment Epithelium / metabolism
  • Vascular Endothelial Growth Factor A / metabolism
  • Vascular Endothelial Growth Factor Receptor-1 / metabolism*

Substances

  • Interleukin-13
  • Vascular Endothelial Growth Factor A
  • Interleukin-4
  • FLT1 protein, human
  • Vascular Endothelial Growth Factor Receptor-1
  • ARG1 protein, human
  • Arginase